TWST

Compare

Twist Bioscience Corp · Healthcare

$191.41

▲ 2.8%Close 2026-09-30

Live intraday price

Compare with our price levels

T2Target T2221.84

T1Target T1198.03

E1Buy zone E1129.97

E3Buy zone E399.88

SLStop-loss SL87.98

Close 2026-09-30: $191.41 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 32.1% · 2 whales recently bought

1 month

▲ 37.7%

3 months

▲ 87.2%

1 year

▲ 608.9%

Analyst target

$109.58 -42.7%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone

E1$129.97 -32.1%

E2$117.74 -38.5%

E3$99.88 -47.8%

Targets

T1$198.03 3.5%

T2$221.84 15.9%

T3$245.64 28.3%

Stop-loss

SL$87.98 -54.0%

Whale cost ~$33.07 -82.7%

Risk : reward 1 : 3.8Moves ~$11.90 a day

⚖️ Positives and risks

✓ Positives (5)

●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 2 ราย
●แนวโน้มระยะยาวเป็นขาขึ้น (เหนือ MA200 และ MA200 ชี้ขึ้น)
●แข็งแกร่งกว่าตลาด (S&P 500) +284% ใน 6 เดือน
●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
●รายได้โต +23% เทียบปีก่อน

! Risks (5)

●เซียนขายออก/ลดสัดส่วน 2 ราย: Stanley Druckenmiller (ขายหมด), Cathie Wood (ลด)
●RSI 75 ซื้อมากเกินไป (Overbought) เสี่ยงย่อตัว
●ราคาห่างเหนือ MA200 ถึง +154% วิ่งมาไกลแล้ว
●ราคาเกินเป้าหมายนักวิเคราะห์เฉลี่ย 109.58 แล้ว (-43%)
●บริษัทยังขาดทุน (อัตรากำไรสุทธิติดลบ)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

Entry/target/SL lines MA50 / MA200 Whale cost Bot trades Volume

🐋 Whales holding this stock

From each whale's latest quarterly filing

CWCathie WoodTrimmed3.04% of port.BBridgewaterNew buy0.01% of port.JGJoel GreenblattNew buy0.00% of port.SDStanley DruckenmillerSold out

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies

Sell

Leproust Emily M. · CEO · Director

2026-09-24 · 2,485 shares @ $175.23 · pre-planned sale (10b5-1)

$435,450

Sell

Leproust Emily M. · CEO · Director

2026-09-24 · 945 shares @ $176.39 · pre-planned sale (10b5-1)

$166,690

Sell

Leproust Emily M. · CEO · Director

2026-09-24 · 515 shares @ $180.39 · pre-planned sale (10b5-1)

$92,901

Sell

Leproust Emily M. · CEO · Director

2026-09-24 · 501 shares @ $183.76 · pre-planned sale (10b5-1)

$92,066

Sell

Leproust Emily M. · CEO · Director

2026-09-24 · 330 shares @ $178.67 · pre-planned sale (10b5-1)

$58,961

Sell

Leproust Emily M. · CEO · Director

2026-09-24 · 164 shares @ $177.17 · pre-planned sale (10b5-1)

$29,056

Sell

Leproust Emily M. · CEO · Director

2026-09-24 · 143 shares @ $179.93 · pre-planned sale (10b5-1)

$25,730

Sell

Leproust Emily M. · CEO · Director

2026-09-24 · 83 shares @ $184.60 · pre-planned sale (10b5-1)

$15,322

Sell

Leproust Emily M. · CEO · Director

2026-09-24 · 21 shares @ $181.45 · pre-planned sale (10b5-1)

$3,810

Sell

Leproust Emily M. · CEO · Director

2026-09-24 · 16 shares @ $182.50 · pre-planned sale (10b5-1)

$2,920

Sell

Leproust Emily M. · CEO · Director

2026-09-21 · 1,687 shares @ $165.49

$279,183

Sell

Cho Dennis · Officer

2026-09-21 · 348 shares @ $165.49

$57,591

Sell

Green Paula · Officer

2026-09-21 · 294 shares @ $165.49

$48,654

Sell

Leproust Emily M. · CEO · Director

2026-09-17 · 232,173 shares @ $158.09 · pre-planned sale (10b5-1)

$37M

Sell

Leproust Emily M. · CEO · Director

2026-09-17 · 32,260 shares @ $157.49 · pre-planned sale (10b5-1)

$5M

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person